NL9001828A - Werkwijze voor het wijzigen van het cel-, weefsel- of gastheertropisme van een microoerganisme; aldus verkregen gerecombineerd microorganisme en toepassing daarvan in de geneeskunde en diergeneeskunde. - Google Patents
Werkwijze voor het wijzigen van het cel-, weefsel- of gastheertropisme van een microoerganisme; aldus verkregen gerecombineerd microorganisme en toepassing daarvan in de geneeskunde en diergeneeskunde. Download PDFInfo
- Publication number
- NL9001828A NL9001828A NL9001828A NL9001828A NL9001828A NL 9001828 A NL9001828 A NL 9001828A NL 9001828 A NL9001828 A NL 9001828A NL 9001828 A NL9001828 A NL 9001828A NL 9001828 A NL9001828 A NL 9001828A
- Authority
- NL
- Netherlands
- Prior art keywords
- microorganism
- cell
- tissue
- microorganism according
- gene
- Prior art date
Links
- 244000005700 microbiome Species 0.000 title claims abstract description 71
- 238000000034 method Methods 0.000 title description 7
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 27
- 239000002773 nucleotide Substances 0.000 claims abstract description 17
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 17
- 230000001939 inductive effect Effects 0.000 claims abstract description 10
- 108700039887 Essential Genes Proteins 0.000 claims abstract description 9
- 230000005101 cell tropism Effects 0.000 claims abstract description 7
- 230000005100 tissue tropism Effects 0.000 claims abstract description 6
- 230000005099 host tropism Effects 0.000 claims abstract description 5
- 108700028146 Genetic Enhancer Elements Proteins 0.000 claims abstract description 4
- 210000004027 cell Anatomy 0.000 claims description 59
- 210000001519 tissue Anatomy 0.000 claims description 33
- 241000700605 Viruses Species 0.000 claims description 31
- 229960005486 vaccine Drugs 0.000 claims description 10
- 108010076876 Keratins Proteins 0.000 claims description 8
- 230000014509 gene expression Effects 0.000 claims description 7
- 102000011782 Keratins Human genes 0.000 claims description 6
- 206010028980 Neoplasm Diseases 0.000 claims description 5
- 230000028993 immune response Effects 0.000 claims description 5
- 102000013127 Vimentin Human genes 0.000 claims description 4
- 108010065472 Vimentin Proteins 0.000 claims description 4
- 241001529453 unidentified herpesvirus Species 0.000 claims description 4
- 210000005048 vimentin Anatomy 0.000 claims description 4
- 108700002232 Immediate-Early Genes Proteins 0.000 claims description 3
- 208000009305 pseudorabies Diseases 0.000 claims description 2
- 239000003623 enhancer Substances 0.000 description 12
- 241000283690 Bos taurus Species 0.000 description 11
- 241000701093 Suid alphaherpesvirus 1 Species 0.000 description 8
- 230000001105 regulatory effect Effects 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000012894 fetal calf serum Substances 0.000 description 4
- 230000010076 replication Effects 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 230000010415 tropism Effects 0.000 description 4
- 238000002255 vaccination Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 101000999689 Saimiriine herpesvirus 2 (strain 11) Transcriptional regulator ICP22 homolog Proteins 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000000120 cytopathologic effect Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000002163 immunogen Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 210000003292 kidney cell Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000005075 mammary gland Anatomy 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 108020005065 3' Flanking Region Proteins 0.000 description 1
- 101000975491 Bos taurus Keratin, type I cytoskeletal 10 Proteins 0.000 description 1
- 108090000565 Capsid Proteins Proteins 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 102100023321 Ceruloplasmin Human genes 0.000 description 1
- 101710163595 Chaperone protein DnaK Proteins 0.000 description 1
- 238000012270 DNA recombination Methods 0.000 description 1
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 1
- 108010007577 Exodeoxyribonuclease I Proteins 0.000 description 1
- 102100029075 Exonuclease 1 Human genes 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 101710178376 Heat shock 70 kDa protein Proteins 0.000 description 1
- 101710152018 Heat shock cognate 70 kDa protein Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000975474 Homo sapiens Keratin, type I cytoskeletal 10 Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000005706 Keratin-6 Human genes 0.000 description 1
- 108010070557 Keratin-6 Proteins 0.000 description 1
- ZQISRDCJNBUVMM-UHFFFAOYSA-N L-Histidinol Natural products OCC(N)CC1=CN=CN1 ZQISRDCJNBUVMM-UHFFFAOYSA-N 0.000 description 1
- ZQISRDCJNBUVMM-YFKPBYRVSA-N L-histidinol Chemical compound OC[C@@H](N)CC1=CNC=N1 ZQISRDCJNBUVMM-YFKPBYRVSA-N 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 108010086093 Mung Bean Nuclease Proteins 0.000 description 1
- 241000699660 Mus musculus Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 102000003946 Prolactin Human genes 0.000 description 1
- 108010057464 Prolactin Proteins 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 102000006601 Thymidine Kinase Human genes 0.000 description 1
- 108020004440 Thymidine kinase Proteins 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 230000022534 cell killing Effects 0.000 description 1
- 230000009391 cell specific gene expression Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000408 embryogenic effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 210000003061 neural cell Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 229940097325 prolactin Drugs 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000011830 transgenic mouse model Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16741—Use of virus, viral particle or viral elements as a vector
- C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL9001828A NL9001828A (nl) | 1990-08-15 | 1990-08-15 | Werkwijze voor het wijzigen van het cel-, weefsel- of gastheertropisme van een microoerganisme; aldus verkregen gerecombineerd microorganisme en toepassing daarvan in de geneeskunde en diergeneeskunde. |
| KR1019930700431A KR0181976B1 (ko) | 1990-08-15 | 1991-08-15 | 미생물의 세포, 조직 또는 숙주 지향성을 변화시키는 방법, 이 방법으로 수득된 재조합 미생물, 및 의학 및 수의학 분야에서 이들을 사용하는 방법 |
| EP91915010A EP0544746B1 (fr) | 1990-08-15 | 1991-08-15 | Procede de modification de la cellule, du tissu ou du tropisme hote d'un microorganisme, microorganismes de recombinaison ainsi obtenus et leurs applications medicales et veterinaires |
| AU84122/91A AU657698B2 (en) | 1990-08-15 | 1991-08-15 | Method for modifying the cell, tissue or host tropism of a microorganism; recombinant microorganisms obtained in this way and use thereof in medicine and veterinary medicine |
| ES91915010T ES2074280T3 (es) | 1990-08-15 | 1991-08-15 | Metodo para modificar el tropismo de celula, tejido o huesped de un microorganismo, microorganismos recombinantes obtenidos de este modo y su uso en medicina y medicina veterinaria. |
| JP3513994A JPH06500096A (ja) | 1990-08-15 | 1991-08-15 | 微生物の細胞、組織又は宿主向性を修飾する方法、この方法で得た組換え微生物並びに医薬及び獣医薬における該組換え微生物の使用 |
| CA002089484A CA2089484A1 (fr) | 1990-08-15 | 1991-08-15 | Methode pour modifier le tropisme d'un micro-organisme pour des tissus cellulaires ou pour un hote; micro-organismes recombinants ainsi obtenus et leur utilisation en medecine humaine et veterinaire |
| HU9300397A HU218742B (hu) | 1990-08-15 | 1991-08-15 | Módosított sejt-, szövet- vagy gazdaszervezet-tropizmussal rendelkező rekombináns mikroorganizmust tartalmazó vakcina |
| AT91915010T ATE121786T1 (de) | 1990-08-15 | 1991-08-15 | Verfahren zur modifizierung von zell-, gewebe- oder wirts-tropismus eines mikroorganismus, so erhaltene rekombinante mikroorganismen sowie deren verwendung in medizin und tiermedizin. |
| DE69109298T DE69109298T2 (de) | 1990-08-15 | 1991-08-15 | Verfahren zur modifizierung von zell-, gewebe- oder wirts-tropismus eines mikroorganismus, so erhaltene rekombinante mikroorganismen sowie deren verwendung in medizin und tiermedizin. |
| PCT/NL1991/000152 WO1992003563A1 (fr) | 1990-08-15 | 1991-08-15 | Procede de modification de la cellule, du tissu ou du tropisme hote d'un microorganisme, microorganismes de recombinaison ainsi obtenus et leurs applications medicales et veterinaires |
| US08/363,202 US5580564A (en) | 1990-08-15 | 1994-12-22 | Method for modifying the cell, tissue or host tropism of microorganisms; recombinant microorganisms obtained in this way and use thereof in medicine and veterinary medicine |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL9001828A NL9001828A (nl) | 1990-08-15 | 1990-08-15 | Werkwijze voor het wijzigen van het cel-, weefsel- of gastheertropisme van een microoerganisme; aldus verkregen gerecombineerd microorganisme en toepassing daarvan in de geneeskunde en diergeneeskunde. |
| NL9001828 | 1990-08-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL9001828A true NL9001828A (nl) | 1992-03-02 |
Family
ID=19857551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL9001828A NL9001828A (nl) | 1990-08-15 | 1990-08-15 | Werkwijze voor het wijzigen van het cel-, weefsel- of gastheertropisme van een microoerganisme; aldus verkregen gerecombineerd microorganisme en toepassing daarvan in de geneeskunde en diergeneeskunde. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0544746B1 (fr) |
| JP (1) | JPH06500096A (fr) |
| KR (1) | KR0181976B1 (fr) |
| AT (1) | ATE121786T1 (fr) |
| AU (1) | AU657698B2 (fr) |
| CA (1) | CA2089484A1 (fr) |
| DE (1) | DE69109298T2 (fr) |
| ES (1) | ES2074280T3 (fr) |
| HU (1) | HU218742B (fr) |
| NL (1) | NL9001828A (fr) |
| WO (1) | WO1992003563A1 (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5698443A (en) * | 1995-06-27 | 1997-12-16 | Calydon, Inc. | Tissue specific viral vectors |
| US6699468B1 (en) | 1994-06-23 | 2004-03-02 | Georgetown University | Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
| US5585096A (en) * | 1994-06-23 | 1996-12-17 | Georgetown University | Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
| WO1996017053A1 (fr) * | 1994-11-28 | 1996-06-06 | Genetic Therapy, Inc. | Vecteurs de replication a specificite tissulaire |
| US5998205A (en) | 1994-11-28 | 1999-12-07 | Genetic Therapy, Inc. | Vectors for tissue-specific replication |
| US6638762B1 (en) | 1994-11-28 | 2003-10-28 | Genetic Therapy, Inc. | Tissue-vectors specific replication and gene expression |
| US6676935B2 (en) | 1995-06-27 | 2004-01-13 | Cell Genesys, Inc. | Tissue specific adenoviral vectors |
| CA2205076A1 (fr) * | 1997-05-14 | 1998-11-14 | Jim Hu | Cassettes pour l'expression episomale en therapie genique |
| US6379674B1 (en) | 1997-08-12 | 2002-04-30 | Georgetown University | Use of herpes vectors for tumor therapy |
| US6900049B2 (en) | 1998-09-10 | 2005-05-31 | Cell Genesys, Inc. | Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| GB9916702D0 (en) * | 1999-07-16 | 1999-09-15 | Cantab Pharma Res | Virus vectors and preparations and their use |
| WO2002068627A2 (fr) | 2001-02-23 | 2002-09-06 | Novartis Ag | Nouvelles constructions de vecteurs |
| US7364727B2 (en) | 2002-07-22 | 2008-04-29 | Cell Genesys, Inc. | Metastatic colon cancer specific promoter and uses thereof |
| AU2003287451A1 (en) | 2002-11-01 | 2004-06-07 | Cell Genesys, Inc. | Cell-specific adenovirus vector comprising ebv-specific promoter |
| US7482156B2 (en) | 2003-10-15 | 2009-01-27 | Cell Genesys, Inc. | Hepatocellular carcinoma specific promoter and uses thereof |
| JP6555973B2 (ja) * | 2015-08-05 | 2019-08-07 | 株式会社マンダム | 汗腺の形態の確認方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1985005629A1 (fr) * | 1984-05-25 | 1985-12-19 | Dana-Farber Cancer Institute | Vecteurs ltr, leurs procedes de preparation et leur utilisation |
| WO1987004463A1 (fr) * | 1986-01-27 | 1987-07-30 | Syntro Corporation | Virus herpetiques attenues, virus herpetiques comprenant de l'adn etranger contenant une sequence d'acide amine et vaccin les contenant |
| JP2583115B2 (ja) * | 1988-09-10 | 1997-02-19 | 財団法人化学及血清療法研究所 | 組換えマレック病ウイルスおよびその製法 |
| AU620477B2 (en) * | 1988-11-30 | 1992-02-20 | Upjohn Company, The | Transgenic mice for the analysis of hair growth |
-
1990
- 1990-08-15 NL NL9001828A patent/NL9001828A/nl not_active Application Discontinuation
-
1991
- 1991-08-15 EP EP91915010A patent/EP0544746B1/fr not_active Expired - Lifetime
- 1991-08-15 DE DE69109298T patent/DE69109298T2/de not_active Expired - Fee Related
- 1991-08-15 HU HU9300397A patent/HU218742B/hu unknown
- 1991-08-15 KR KR1019930700431A patent/KR0181976B1/ko not_active IP Right Cessation
- 1991-08-15 ES ES91915010T patent/ES2074280T3/es not_active Expired - Lifetime
- 1991-08-15 JP JP3513994A patent/JPH06500096A/ja active Pending
- 1991-08-15 CA CA002089484A patent/CA2089484A1/fr not_active Abandoned
- 1991-08-15 AU AU84122/91A patent/AU657698B2/en not_active Ceased
- 1991-08-15 WO PCT/NL1991/000152 patent/WO1992003563A1/fr active IP Right Grant
- 1991-08-15 AT AT91915010T patent/ATE121786T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH06500096A (ja) | 1994-01-06 |
| EP0544746A1 (fr) | 1993-06-09 |
| ATE121786T1 (de) | 1995-05-15 |
| KR930701610A (ko) | 1993-06-12 |
| HU9300397D0 (en) | 1993-05-28 |
| DE69109298D1 (de) | 1995-06-01 |
| CA2089484A1 (fr) | 1992-02-16 |
| HU218742B (hu) | 2000-11-28 |
| WO1992003563A1 (fr) | 1992-03-05 |
| KR0181976B1 (ko) | 1999-04-01 |
| AU657698B2 (en) | 1995-03-23 |
| DE69109298T2 (de) | 1995-09-21 |
| ES2074280T3 (es) | 1995-09-01 |
| EP0544746B1 (fr) | 1995-04-26 |
| AU8412291A (en) | 1992-03-17 |
| HUT68379A (en) | 1995-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL9001828A (nl) | Werkwijze voor het wijzigen van het cel-, weefsel- of gastheertropisme van een microoerganisme; aldus verkregen gerecombineerd microorganisme en toepassing daarvan in de geneeskunde en diergeneeskunde. | |
| KR100372934B1 (ko) | 형질 상보성 세포주에 의해 생성된 바이러스 결손 백신 | |
| JP3159446B2 (ja) | 組換えアデノウイルス | |
| JP7118062B2 (ja) | リサウイルス抗原を有するチンパンジーアデノウイルス構築物 | |
| DE60035124T2 (de) | Ein oncolytisches adenovirus | |
| JP4365023B2 (ja) | 組換えブタ・アデノウイルス・ベクター | |
| JPH10507061A (ja) | アデノウイルス中にパッケージされたプラスミドｄｎａを用いる遺伝子送達ベクターおよびパッケージング細胞株 | |
| JPH11502222A (ja) | 遺伝子供給用ベクター | |
| HU230488B1 (hu) | Simian adenovírus nukleinsav és aminosav-szekvencia, azt tartalmazó vektorok, és eljárások annak alkalmazására | |
| CN110628730B (zh) | 表达猪繁殖与呼吸综合征病毒gp蛋白的重组猪伪狂犬病病毒及应用 | |
| JP2001508304A (ja) | 細胞内及び細胞間輸送のための融合タンパク質、並びにその使用 | |
| JPH08508879A (ja) | 腫瘍の遺伝子療法のための欠陥組換えアデノウイルス | |
| KR0153005B1 (ko) | 제조합 마레크병 바이러스 | |
| WO2019016756A1 (fr) | Constructions d'antigène du virus chikungunya | |
| Bailer et al. | Herpesviral vectors and their application in oncolytic therapy, vaccination, and gene transfer | |
| JP2017526737A (ja) | 組み換え血清型９トリアデノウイルスベクター形式でのワクチン | |
| Ning et al. | Evaluation of the safety and immunogenicity of duck-plague virus gE mutants | |
| JP2786625B2 (ja) | 単純ヘルペスウイルスタンパク質をコードするｄｎａ配列 | |
| Li et al. | Immunogenicity assessment of rift valley fever virus virus-like particles in BALB/c mice | |
| KR100845192B1 (ko) | Ｇｍ-음성 ｅｈｖ-돌연변이 | |
| US5580564A (en) | Method for modifying the cell, tissue or host tropism of microorganisms; recombinant microorganisms obtained in this way and use thereof in medicine and veterinary medicine | |
| JPH09505726A (ja) | 組換え感染性喉頭気管炎ウイルス及びそれらの使用 | |
| Glazenburg et al. | Construction and properties of pseudorabies virus recombinants with altered control of immediate-early gene expression | |
| KR20010086357A (ko) | 재조합 ｃｅｌｏ 바이러스 및 ｃｅｌｏ 바이러스 ｄｎａ | |
| JPH09508005A (ja) | 潜伏と腫瘍細胞発生の阻害によるマレク病の抑制 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1B | A search report has been drawn up | ||
| BV | The patent application has lapsed |